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Abstract. Human immunodeficiency virus (HIV) is common in pregnant women in many malaria-endemic regions
and may increase risk of placental parasitemia. Placental malaria is more common in primigravidae than multigravidae,
but the relationship between HIV and malaria across gravidities is not well characterized. We recruited pregnant
Malawian women during the second trimester and followed them until delivery. Parasitemia was assessed at enrollment,
follow-up visits, and delivery, when placental blood was sampled. There was no difference in risk of parasitemia between
HIV-positive and HIV-negative primigravidae. Among multigravidae, HIV-infected women had greater than twice the
risk of parasitemia as HIV-uninfected women throughout follow-up. Human immunodeficiency virus was also associated
with more frequent peripheral parasitemia in multigravidae but not primigravidae. Both HIV and primigravid status
were independently associated with higher peripheral and placental parasite densities. Although risk of parasitemia is
lower in multigravidae than primigravidae, the HIV effect on risk of malaria is more pronounced in multigravidae.
INTRODUCTION
Each year, more than 20 million women become pregnant
in malaria-endemic areas of Africa.1,2 Infection with Plasmo-
dium falciparum during pregnancy contributes to 75,000 to
200,000 infant deaths per year.3 Placental malaria is associ-
ated with spontaneous abortion and stillbirth and intrauterine
growth retardation, prematurity, and severe maternal anemia,
which are risk factors for low birth weight and neonatal mor-
tality.4,5 Placental malaria occurs when pregnant women are
infected by particular strains of P. falciparum that produce
variant surface antigens on the surface of red blood cells with
special affinity for receptors expressed on the surface of pla-
cental cells, specifically chondroitin sulfate A. These variants
exclusively cause disease in pregnant women, so primigravidae
are generally at highest risk of infection with these variants
because of their lack of previous exposure. With succes-
sive pregnancies, women gradually develop immunity to these
pregnancy-specific parasite populations; thus, the risk of pla-
cental malaria decreases in later pregnancies.6
Human immunodeficiency virus (HIV)-infected persons are
at increased risk of clinical malaria compared with HIV-
uninfected persons and have a poorer response to antimalarial
drugs in some studies.7–10 The HIV increases the risk of mater-
nal parasitemia during pregnancy11 and of congenital malaria
in the infant.12 Although congenital malaria is uncommon, it
has been associated with poor maternal antibody response to
malaria antigens in HIV-positive women.12 The effect of HIV
on malaria risk during pregnancy is complex, however, and
appears to differ between primigravid and multigravid women.
Many studies have shown an increased risk of placental
parasitemia in multigravid women infected with HIV,
suggesting that the relative protection from placental malaria
that arises with subsequent pregnancies may be attenuated by
HIV infection13–16; there is no evidence suggesting that HIV
infection increases the risk of parasitemia in primigravidae.
Many of the existing studies investigating this relationship
between HIV infection and malaria during pregnancy have
been cross-sectional, limiting ability to detect variation in risk
of malaria over the course of pregnancy. To evaluate the
effect of HIV infection on risk of parasitemia and placental
malaria in both primigravid and multigravid women, we
conducted a longitudinal study of pregnant women in south-
ern Malawi, where the prevalence of HIV in prenatal clinics
is ~12% and malaria is endemic.17
METHODS
Study population and study site. The study population
consisted of all healthy women in their second trimester of
pregnancy attending the Mpemba and Madziabango Health
Centers in Blantyre District in southern Malawi for antenatal
care and delivery between March 2005 and February 2006.
These two health centers are located in rural areas outside
Blantyre, Malawi’s second largest city. Exclusion criteria
included declining voluntary counseling and testing for HIV.
Data collection. Participants were administered a question-
naire by the study nurses at enrollment about demographic
characteristics, socio-economic factors, and malaria preven-
tion behaviors. Participating women were encouraged to
attend visits at 26, 32, and 36–38 weeks gestation according
to standard antenatal care guidelines. Women were adminis-
tered sulfadoxine-pyrimethamine (SP) for intermittent pre-
ventive therapy in pregnancy (IPTp) or treated for clinical
malaria according to national guidelines. The HIV-infected
women were given nevirapine during labor and their infants
were treated with nevirapine after delivery according to
Malawi’s national guidelines at the time. All HIV-infected
women were referred to an antiretroviral treatment program.
Laboratory procedures. Participants were screened for
HIV infection at enrollment with two rapid HIV-1 antibody
tests: Determine (InvernessMedical Innovations, Inc., Waltham,
MA) and Unigold (Trinity Biotech, Bray, Ireland). The HIV
infection was defined as a positive result by both rapid tests.
There was greater than 95% agreement between the two tests.
Patients with discordant results were excluded from analyses. At
each visit, a blood sample was collected by finger prick for
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preparation of thick blood smears on slides. Peripheral malaria
parasitemia was assessed through microscopic examination of
stained thick blood smear slides on site by trained laboratory
technicians. At delivery, placental, cord, and peripheral blood
samples were collected, and thick blood smears were prepared
and examined as described previously. For quality control, 10%
of randomly selected slides were re-examined by the laboratory
supervisor at Ntcheu District Hospital.
Outcomes. Parasitemia was defined as the presence of para-
sites in thick blood smears. Malaria parasites were quantified
against 200 white blood cells (WBCs). Parasite density was
calculated assuming 6,000 WBCs/mL of blood. Frequency of
peripheral parasitemia over follow-up was defined as the num-
ber of episodes of parasitemia during follow-up visits. Because
we could not distinguish between recrudescence and reinfec-
tion, episodes of parasitemia were assumed to be independent
across visits. Parasitemia was analyzed in four ways: 1) the
presence or absence of parasitemia at enrollment, delivery,
and anytime during the follow-up period; 2) average longitudi-
nal risk of parasitemia during follow-up, which is the marginal
probability of developing parasitemia over follow-up taking
into account clustering, i.e., the possibility of more than one
parasitemia episode per woman; 3) number of episodes of
parasitemia during follow-up; and 4) peripheral and placental
parasite density at delivery.
Statistical analysis. Binomial regression was used to esti-
mate prevalence and risk ratios for parasitemia. Parasitemia
risk over visits was analyzed using weighted generalized esti-
mating equations (wGEE) to account for the possibility that
data were missing at random. In these models, each individual
response is weighted by the inverse probability of a missing
response given the other responses, i.e., the probability of a
missing measurement given the other measurements for a
given subject.18 We used the following model of covariates to
estimate the weight:




where qhi = Pr{missing response at visit h j non-missing
response at visit h-1}. In the above model, h indexes visits,
i indexes subjects, and k indexes covariates. The set of
covariates used in the dropout model included continuous
maternal weight in kg, maternal age at enrollment, indicators
for access to an unsafe water source, < 8 years of education,
primigravidity, husbands’ occupation, and low housing qual-
ity. The polytomous outcome, number of parasitemia epi-
sodes, was analyzed using generalized logistic regression.
Parasite density at delivery was analyzed using zero-inflated
negative binomial (ZINB) regression. The advantage of ZINB
regression is that it takes into account the semi-continuous
nature (excess zeros) of parasite density and allows for
overdispersion in nonzero values of parasite density. This is
preferable to comparing geometric mean parasite density
using Student’s t test and analysis of variance or to performing
analyses on log-transformed parasite density for two reasons.
First, because of the high degree of skew in parasite density,
log-transformation may not result in a normal distribution of
transformed values precluding use of tests with a normality
assumption; additionally, the optimal Box-Cox transforma-
tion that would result in a normal distribution may vary from
population to population, given factors such as seasonality
and transmission intensity that tend to differ across populations.
Second, back-transformation of transformed values may not
result in sensible results. The ZINB regression appropriately
takes into account the distribution of parasite density and
allows for the estimation of a predicted mean change in parasite
density, which has use in determining the impact of the risk/
protective factors of interest on parasite burden.
Covariate inclusion in regression modeling was decided
using a causal diagram. Malaria preventive behaviors are
endogenous to socioeconomic/demographic factors so these
variables were coupled together. Age and gravidity were cor-
related to the point of exchangeability; therefore, gravidity
was chosen for analysis because it was the main confounder
of interest. The wGEE were conducted using the macro
developed by Molenbergh and Verbeke.18 All analyses except
one were conducted using SAS version 9.1 for Windows (SAS
Inc., Cary, NC). Zero-inflation negative binomial regression
was conducted using StataSE version 10 (StataCorp., College
Station, TX).
Ethical considerations. Informed consent was obtained from
all participating women. The study was approved by the insti-
tutional review boards of the University of North Carolina at
Chapel Hill and the University of Malawi College of Medicine.
RESULTS
One thousand four hundred ninety-six (1,496) preg-
nant women were approached about the study; of these,
111 women did not agree to voluntary counseling and testing
for HIV, 15 had discordant HIV rapid test results, and 4 others
were not available for follow-up. The remaining 1,366 women
were included in the analyses, and 831 (61%) were followed
until delivery. The characteristics of participating women are
presented in Table 1. The HIV-infected primigravidae had
higher educational attainment and higher rates of reported
bed net use and bed net treatment with insecticide at regular
intervals than HIV-uninfected primigravidae. A higher pro-
portion of HIV-infected primigravidae reported receiving
antimalarials for treatment of clinical malaria during preg-
nancy before enrollment than HIV-uninfected primigravidae.
These differences were not observed among multigravidae.
During the follow-up period, 605 women (41%) experienced
at least one episode of parasitemia (Table 2 and Figure 1). Of
these women, 35% experienced more than one episode. For
primigravidae, at enrollment, HIV-infected women had a
lower prevalence of parasitemia (43.5%) than HIV-uninfected
women (58.9%), and this difference diminished over time.
These differences were not significant and were likely caused
by differences in behaviors described previously. In contrast,
among multigravidae, HIV-infected women were consistently
more likely to be parasitemic than HIV-uninfected women at
all time points.
Women with higher levels of education and higher bed net
use were, in general, protected against parasitemia. In multi-
variate analysis, low educational attainment among primi-
gravidae was associated with parasitemia at enrollment
(prevalence ratio [PR] = 2.25, 95% confidence interval [CI]:
1.29, 3.91) and anytime over follow-up (risk ratio [RR] = 1.80,
95% CI: 1.01, 3.30). There was a similar but non-significant
trend among multigravidae, in whom the effect estimates were
1.76 (95% CI: 0.40, 2.15) and 1.10 (95% CI: 0.64, 1.90), respec-
tively. Reported use of a bed net was inversely associated with
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parasitemia at enrollment among primigravidae (PR = 0.64,
95% CI: 0.34, 1.21) and multigravidae (PR = 0.67, 95%CI:
0.47, 0.97). For developing parasitemia anytime over follow-up,
the effect of bed nets was more pronounced among primi-
gravidae (RR = 0.47, 95% CI: 0.23, 0.94) than among multi-
gravidae (RR = 0.89, 95% CI: 0.61, 1.30).
The effect of HIV infection on parasitemia is presented in
Table 3. After adjusting for education, maternal weight, bed
net use, and number of IPTp doses received, HIV-infected
primigravidae were slightly less likely to have parasitemia at
enrollment; however, this result was not significant and was
imprecise with a confidence limit ratio of 6.2. Similarly, there
was no difference in risk of parasitemia during follow-up or
delivery between HIV-infected and HIV-uninfected primi-
gravidae. In contrast, there was a significant difference in prev-
alence of parasitemia in HIV-positive and HIV-negative
multigravid women at all time points, with HIV-positive women
being 2.16–2.44 times as likely to be parasitemic. Results from
wGEE for primigravidae were unreliable because of zero cell
counts at some visits; for multigravid women, wGEE revealed
that HIV-positive women had a 2.63 times higher average risk
of parasitemia than HIV-negative women. Thus, HIV infection
increased the likelihood of malaria parasitemia in multigravidae
but not in primigravidae.
Multivariate analysis of risk factors for number of episodes
of parasitemia is shown in Table 4. Among multigravidae,
HIV infection was associated with more episodes of para-
sitemia, with a RR of 4.82 (95% CI: 2.12, 10.96) for more than
three episodes. The HIV was not significantly associated with
a higher frequency of parasitemia in primigravid women. Low
educational level and bed net use were not associated with
frequency of parasitemia. Receiving exactly two doses of SP
IPTp appeared slightly protective against repeated episodes
of parasitemia when compared with just one or more than
three doses.
At delivery, infection with HIV was associated with higher
peripheral and placental parasite densities than in HIV-
uninfected women when adjusted for gravidity, maternal
weight, and bed net use, with a greater effect estimate observed
in the placenta (Table 5). Independent of HIV infection,
primigravidity was associated with higher peripheral and pla-
cental parasite densities, an effect again more pronounced in
placental samples. Although both reported bed net use and
regular insecticide impregnation of the bed net were associated
with lower peripheral parasite densities, only reported insecti-
cide treatment of bed nets was associated with lower placental
parasite densities.
DISCUSSION
In this article, we report the effect of HIV infection on
malaria parasitemia in a cohort of pregnant women observed
from the second trimester until delivery. The HIV infection
was associated with a higher prevalence of parasitemia at
Table 1











Maternal age(years), mean ± SD 19.2 ± 2.7 18.3 ± 1.9 26.5 ± 4.2 25.3 ± 5.3
Education £ 8 years (%) 43.5 80.7 89.4 89.9
Married (%) 65.2 81.6 94.4 96.1
Unemployed (%) 52.2 61.1 46.3 51.1
Report receiving antimalarials for malaria before enrollment (%) 21.7 5.1 13.6 9.6
Report always using bed net (%) 34.8 13.0 24.1 25.9
Report insecticide impregnation of bed net in past 6 months (%) 30.4 11.5 22.8 22.3
Weight (kg), mean ± SD 56.9 ± 7.8 53.6 ± 5.7 54.7 ± 6.8 55.1 ± 6.9
Report receiving IPTp before enrollment (%) 21.7 4.4 11.7 6.6
SP doses received in follow up (%)
0 8.7 5.1 8.6 5.9
1 26.1 19.6 32.7 26.9
2 30.4 38.6 32.7 38.5
3+ 34.8 36.7 25.9 28.7
Anemia at enrollment (Hb £ 10 g/dL) (%) 31.8 43.1 35.8 15.0
Anemia at delivery (Hb £ 10 g/dL) (%) 15.4 8.9 20.3 7.4
Birth weight (grams), mean ± SD 2767 ± 514 2931 ± 428 2968 ± 544 3140 ± 461
*HIV = human immunodeficiency virus; kg = kilograms; IPTp = intermittent preventive therapy in pregnancy; SP = sulfadoxine-pyrimethamine; g/dL = grams per deciliter.
Table 2











Percent parasitemic at enrollment (95% CI) 43.5 (23.1, 65.5) 58.9 (53.2, 64.3) 37 (30.0, 45.0) 20.7 (18.0, 23.5)
Percent with placental parasitemia (95% CI) 28.6 (8.4, 58.1) 22.3 (16.7, 28.6) 19.3 (11.6, 29.1) 8.3 (5.9, 11.2)
Percent with peripheral parasitemia at delivery (95% CI) 28.6 (8.4, 58.1) 21.3 (15.9, 27.6) 20.5 (12.6, 30.4) 8.3 (5.9, 11.2)
Percent with parasitemic episodes over pregnancy
0 episodes (95% CI) 47.8 (26.8, 69.4) 27.9 (23.0, 33.1) 50 (42.1, 57.9) 67.7 (64.5, 70.9)
1 episode (95% CI) 26.1 (10.2, 48.4) 37 (31.7, 42.6) 30.9 (23.9, 38.6) 26.1 (23.2, 29.2)
2 episodes (95% CI) 4.4 (0.1, 21.9) 20.9 (16.5, 25.8) 8.6 (4.8, 14.1) 5.6 (4.1, 7.3)
3+ episodes (95% CI) 21.7 (7.5, 43.7) 14.2 (10.6, 18.6) 10.5 (6.2, 16.3) 1.2 (0.6, 2.1)
*HIV = human immunodeficiency virus; CI = confidence interval.
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enrollment and with increased frequency of peripheral para-
sitemia during follow-up in multigravid but not primigravid
women. It was associated with a higher prevalence of placental
parasitemia regardless of gravidity.
We expected to see a higher prevalence of parasitemia in
HIV-infected primigravid women compared with HIV-
uninfected primigravidae but instead found a lower preva-
lence of parasitemia in women with HIV infection, though
this was not significant.13,14,16,19 This lack of association might
be caused by higher levels of educational attainment (nega-
tively associated with risk of parasitemia in our cohort) and
more frequent malaria preventive behaviors reported by
HIV-infected primigravidae compared with HIV-uninfected
primigravidae. In multivariate analyses, there was no differ-
ence in the prevalence ratio for malaria parasitemia between
HIV-infected and uninfected primigravidae.
In contrast, HIV-infected multigravidae were more likely
to be parasitemic than HIV-uninfected multigravidae. Among
multigravidae, HIV infection doubled the risk of parasitemia
at any time during follow-up; this effect was also seen when
estimating the average risk of parasitemia over follow-up.
Ordinarily, multigravidae are protected against malaria com-
pared with primigravidae. In our study, HIV infection nulli-
fied this protective effect.
For most women, the enrollment visit was their first ante-
natal clinic visit and should have been the first visit at which
they would have received IPTp; however, HIV-infected
primigravidae were five times as likely as HIV-uninfected
primigravidae to report receiving an IPTp dose before enroll-
ment. The reason for this finding is not known and could be
related to this group’s higher educational status, which may
indicate greater access to social services such as schools and
health care. Alternatively, HIV-infected primigravidae may
have been more likely to experience parasitemia early in
pregnancy before enrolling in the study. Consistent with this
hypothesis, HIV-infected primigravidae were more than four
times as likely to report having received antimalarial treat-
ment during the pregnancy before enrollment. A similar rela-
tionship was not observed among multigravidae, but it is well
established that immunity to malaria during pregnancy
increases with subsequent pregnancies.6 Both elevated preva-
lence of parasitemia in HIV-positive women in the first tri-
mester and treatment with antimalarials before initiation of
IPTp has been observed in another study from Malawi.13
Higher risk for malaria infection for HIV-infected women in
early pregnancy and consequent treatment before enrollment
may have contributed to the lower prevalence of parasitemia
at enrollment.
As shown in Figure 1, the risk difference for parasitemia
caused by HIV infection among multigravidae did not change
significantly across follow-up visits, suggesting a constant
effect of HIV infection on risk of parasitemia in multigravid
women. In contrast, the risk difference for parasitemia caused
by HIV infection in primigravid women increased across
visits, suggesting that the effect of HIV infection on para-
sitemia risk may vary over the course of pregnancy; however,
Figure 1. Parasitemia across visits among primigravidae and multigravidae (Note: Value for visit 2 carried over to visit 3 among human
immunodeficiency virus (HIV)-infected primigravidae due to sparseness of data).
Table 3







(95% CI)Time point HIV+ HIV− HIV+ HIV−
Enrollment 10/23 (43.5) 186/316 (58.9) 0.85 (0.34–2.12) 60/162 (37.0) 179/865 (20.7) 2.28 (1.58–3.28)
Anytime during follow-up* 8/20 (40) 121/291 (41.6) 1.04 (0.38–2.81) 48/140 (34.3) 148/760 (19.5) 2.16 (1.45–3.21)
Delivery 4/14 (28.6) 45/202 (21.3) 1.66 (0.7–2.81) 17/88 (20.5) 37/447 (8.3) 2.44 (1.2–4.66)
Average risk over follow-up*† – – – Varies Varies 2.63 (1.08–6.44)
Models adjusted for education, maternal weight, bed net use, and number of SP doses received.
*Excludes enrollment visit, risk ratio.
† Primigravidae weighted generalized estimating equations (wGEE)1 results not reported because of sparseness of data across visits, average risk over follow-up, frequencies vary according
to visit.
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our cohort included a relatively small number of HIV-positive
primigravid women, which limits our ability to draw conclu-
sions about this relationship.
The finding that HIV infection is associated with a higher
number of parasitemic episodes during pregnancy corroborates
previous literature. In a study conducted in Malawian non-
pregnant adults, HIV infection increased the hazard of one
episode 1.8 times (95% CI: 1.2, 2.7), and two episodes 2.5 times
(95% CI: 1.5, 4.2)20; in this study, we report similar and more
precise estimates for one and two episodes among multi-
gravidae. We also found a modest association between HIV
infection and having three or more episodes of parasitemia
among multigravidae, a relationship that was not observed in
primigravidae.
The elevated risk of placental parasitemia observed among
primigravidae and multigravidae support findings from pre-
vious studies. An association between HIV infection and
higher parasite density has been reported elsewhere.14,21,22 In
a meta-analysis of the effect of HIV infection on malaria
parasitemia examining four studies, three of which were con-
ducted in Malawi, ter Kuile and others16 reported a summary
RR estimate of 1.27 (95% CI: 1.06, 1.51) for the effect of HIV
infection on placental parasitemia among primigravidae and
2.39 (95% CI: 1.87, 3.07) among grand multigravidae. The
PRs we report in Table 5 are very similar in magnitude to
those results, supporting the hypothesis that the effect of
HIV infection on placental parasitemia is more marked
among multigravidae than among primigravidae. Across gra-
vidities, HIV infection was associated with higher parasite
density, though gravidity itself was not associated with para-
site density.
There were some limitations to our study. Almost 40% of
women included in the analyses were lost to follow-up, which
may limit the generalizability of the results. There were no
significant differences at enrollment between women lost to
follow-up and women followed until delivery; furthermore,
potential residual differences were accounted for in the ana-
lyses. Additionally, in the longitudinal analysis, we accounted
for loss to follow-up by weighting our analysis model by the
inverse probability of being missing given a set of covariates
that could potentially influence missingness. Placental
parasitemia was determined by microscopy of thick smears
instead of placenta histology, a more sensitive method that
was not available for this study. Because we were unable to
distinguish between recrudescence and reinfection in partici-
pants with multiple episodes of parasitemia, some women
labeled as having multiple parasitemia episodes may have
had chronic infection.
An additional limitation is that we did not measure CD4
count, which has been associated with parasitemia in previous
studies.20–22 Consequently, the differences observed among
primigravidae and multigravidae in the effect of HIV infec-
tion on parasitemia may reflect more advanced HIV disease
in multigravidae, who were older. We also did not collect data
on the use of cotrimoxazole by HIV-infected women, which
has been shown to be protective against malaria23 and could
be a confounder by lowering the risk of parasitemia among
HIV-infected women taking the drug. Cotrimoxazole use was
not standard of care in Malawi when this study was
conducted, therefore we expect that few women received the
drug. Furthermore, if HIV infection is associated with early
pregnancy loss, enrollment of HIV-infected women with suf-
ficiently healthy pregnancies to reach the second trimester
may have resulted in selection bias. This may be associated
with other factors such as socioeconomic status and may be
differential according to gravidity, because primigravidae are
generally at much higher risk of adverse pregnancy outcomes
than multigravidae.
There are however, some unique strengths to our study.
The longitudinal study design and analytical procedures
enabled examination of parasitemia risk from the second tri-
mester until delivery. Additionally, the richness of socio-
demographic information recorded from the women that
allowed for a comprehensive missingness model also allowed
Table 4
Multivariate analysis of risk factors for number of episodes of parasitemia














HIV infection 0.76 (0.38–1.54) 1.31 (1.02–1.67) 1.40 (0.68–2.89) 2.20 (1.53–3.15) 1.49 (0.64–3.51) 4.82 (2.12–10.96)
Less than 8 years of education 1.08 (0.78–1.51) 1.06 (0.77–1.46) 1.77 (0.99–3.15) 0.86 (0.52–1.43) 1.98 (0.90–4.37) N/A
Report always using bed net 0.64 (0.42–0.99) 0.96 (0.77–1.19) 0.62 (0.32–1.17) 0.96 (0.18–5.00) 1.01 (0.55–1.85) 0.95 (0.41–2.20)
SP doses received
0–1 1.44 (0.96–2.17) 1.19 (0.93–1.53) 1.03 (0.57–1.84) 0.73 (0.45–1.18) 0.54 (0.19–1.55) N/A
2 0.75 (0.55–1.01) 0.97 (0.78–1.20) 0.63 (0.42–0.96) 0.68 (0.47–1.00) 0.50 (0.29–0.86) 0.48 (0.21–1.10)
3+ Reference Reference Reference Reference Reference Reference
PR = prevalence ratio; RR = risk ratio; CI = confidence interval; Primigravidae (N = 339), Multigravidae (N = 1122).
*Excluding enrollment visit.
Table 5
Multivariate predictors of peripheral and placental parasite density at delivery
Peripheral Placental
Variable Ratio of average densities (95% CI) Ratio of average densities (95% CI)
HIV infection 2.59 (1.25–5.34) 3.56 (1.76–7.21)
Primigravid 2.03 (1.11–3.73) 3.97 (2.16–7.30)
Maternal weight, kilograms (continous) 0.94 (0.89–1.00) 0.89 (0.85–0.92)
Report always using bed net* 0.42 (0.20–0.87) 1.22 (0.57–2.62)
Report insecticide impregnation in past 6 months 0.35 (0.17–0.73) 0.19 (0.04–0.94)
CI = Confidence Interval, SD = Standard deviation, N= 831.
*All variables in model. Bed net model excludes insecticide impregnation variable.
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for the examination of the role of other individual factors in
determining parasitemia risk over the follow-up period.
With the reduced effectiveness of SP IPTp among HIV-
infected women, it is important that antenatal care services
promote the full repertoire of malaria prevention methods.
The study underscores the necessity of targeting both
primigravidae and multigravidae for malaria prevention in
areas with a high prevalence of HIV infection. Although we
report an elevated risk of parasitemia among multigravidae
throughout the second and third trimesters, our results sug-
gest that the effect of HIV infection on parasitemia risk may
be less important for primigravidae, who are at higher risk of
malaria than multigravidae. Further studies are needed to
understand the effect of HIV infection on parasitemia risk
over the course of pregnancy.
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